San Diego company hopes to monitor COVID with a patch (a mark from nanobeads) Posted on Short 2:43 minute News Clip on YouTube Yes, they are developing a patch that works for several days. But, they are developing injectables that leave a "mark" on the skin for over a year. TOPICS: Beast 2 Internet? Specifically the Tech giants/social media There's lots happening and moving incredibly fast. This short video just sliced and diced where the world is heading ... GOLDEN, Colo.—(BUSINESS WIRE)— PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free Injection System will be used by Diomics, a San Diego-based biotech company, to deliver a biopolymer to detect the formation of an immune response to a SARS-CoV-2 protein. The company was awarded over $2 million by the Department of Defense to accelerate testing of its Diocheck™ system and is expected to begin human clinical trials in December 2020.